These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35895373)

  • 1. Apelin Association with Hepatic Fibrosis and Esophageal Varices in Patients with Chronic Hepatitis C Virus.
    Soliman LA; Zayed RA; Omran D; Said F; Darweesh SK; Ghaith DM; Eletreby R; Barakat MS; Bendary MM; Zaky DZ; Amer E; Elmahgoub IR
    Am J Trop Med Hyg; 2022 Jul; 107(1):190-197. PubMed ID: 35895373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patients?
    Hassan EM; Omran DA; El Beshlawey ML; Abdo M; El Askary A
    Gastroenterol Hepatol; 2014 Feb; 37(2):58-65. PubMed ID: 24365388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the influence of heme oxygenase 1 gene single nucleotide polymorphism (rs2071746) on esophageal varices among patients with cirrhosis.
    Ellakany WI; Mahmoud MoheyEldin K; Invernizzi P; Mahmoud ElKady A; Eldin Fathy Abou Elkheir H; Abdel Haleem Abo Elwafa R; Ellakany A
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):888-892. PubMed ID: 29877949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors.
    Pan WD; Xun RY; Chen YM
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):527-31. PubMed ID: 14607680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis.
    Calvaruso V; Bronte F; Conte E; Simone F; Craxì A; Di Marco V
    J Viral Hepat; 2013 Dec; 20(12):867-74. PubMed ID: 24304456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apelin is a marker of the progression of liver fibrosis and portal hypertension in patients with biliary atresia.
    Chen W; Oue T; Ueno T; Uehara S; Usui N; Fukuzawa M
    Pediatr Surg Int; 2013 Jan; 29(1):79-85. PubMed ID: 23160902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
    Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q
    Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of non-selective beta blockers on portal hypertension and hepatic elasticity in hepatitis C virus-related liver cirrhosis.
    Zaghloul SG; Wahab EA; Seleem WM; Hanafy AS; Gomaa AF; Lakouz K; Amin AI
    Drug Discov Ther; 2019; 13(2):108-113. PubMed ID: 31080201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients.
    Stefanescu H; Grigorescu M; Lupsor M; Procopet B; Maniu A; Badea R
    J Gastroenterol Hepatol; 2011 Jan; 26(1):164-70. PubMed ID: 21175810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation Between Severity Of Portal Hypertensive Gastropathy And Size Of Oesophageal Varices In Cirrhotic Hepatitis-C Patients.
    Saleem K; Baig FA; Nida M; Javed M
    J Ayub Med Coll Abbottabad; 2018; 30(1):54-57. PubMed ID: 29504330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis.
    Morishita N; Hiramatsu N; Oze T; Harada N; Yamada R; Miyazaki M; Yakushijin T; Miyagi T; Yoshida Y; Tatsumi T; Kanto T; Takehara T
    J Gastroenterol; 2014 Jul; 49(7):1175-82. PubMed ID: 24005957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.
    Sanyal AJ; Fontana RJ; Di Bisceglie AM; Everhart JE; Doherty MC; Everson GT; Donovan JA; Malet PF; Mehta S; Sheikh MY; Reid AE; Ghany MG; Gretch DR; Halt-C Trial Group
    Gastrointest Endosc; 2006 Dec; 64(6):855-64. PubMed ID: 17140886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen and liver stiffness for noninvasive assessment of portal hypertension in cirrhotic patients with large esophageal varices.
    Tseng Y; Li F; Wang J; Chen S; Jiang W; Shen X; Wu S
    J Clin Ultrasound; 2018 Sep; 46(7):442-449. PubMed ID: 30132919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two findings of portal hypertension: evaluation of correlation between serum-ascites albumin gradient and esophageal varices in non-alcoholic cirrhosis.
    Demirel U; Karincaoğlu M; Harputluoğlu M; Ateş M; Seçkin Y; Yildirim B; Hilmioğlu F
    Turk J Gastroenterol; 2003 Dec; 14(4):219-22. PubMed ID: 15048594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial.
    Fontana RJ; Sanyal AJ; Mehta S; Doherty MC; Neuschwander-Tetri BA; Everson GT; Kahn JA; Malet PF; Sheikh MY; Chung RT; Ghany MG; Gretch DR;
    Am J Gastroenterol; 2006 May; 101(5):983-92. PubMed ID: 16573786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study.
    Annicchiarico BE; Santonocito C; Siciliano M; Scapaticci M; Guarino D; Di Stasi C; Riccioni ME; Di Stasio E; Capoluongo E; Gasbarrini A
    Dig Liver Dis; 2019 Feb; 51(2):293-296. PubMed ID: 30236768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis.
    Montes Ramirez ML; Pascual-Pareja JF; Sánchez-Conde M; Bernardino De la Serna JI; Zamora Vargas FX; Miralles P; Castro JM; Ramírez M; Gutierrez I; Gonzalez-García J; Berenguer J; Arribas López JR
    AIDS; 2012 Sep; 26(14):1807-12. PubMed ID: 22781218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis.
    Vizzutti F; Arena U; Romanelli RG; Rega L; Foschi M; Colagrande S; Petrarca A; Moscarella S; Belli G; Zignego AL; Marra F; Laffi G; Pinzani M
    Hepatology; 2007 May; 45(5):1290-7. PubMed ID: 17464971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of major complications in hepatitis C virus-related cirrhosis evaluated by per-rectal portal scintigraphy.
    Kawamura E; Habu D; Hayashi T; Oe A; Kotani J; Ishizu H; Torii K; Kawabe J; Fukushima W; Tanaka T; Nishiguchi S; Shiomi S
    World J Gastroenterol; 2005 Jul; 11(25):3882-6. PubMed ID: 15991287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.